ClinicalTrials.gg
Not yet recruitingNCT06572878Updated Aug 27, 2024

Evaluation of Cognitive and Physical Training on MCI Elders

An interventional study of Cognitive training and Physical training in Cognitive Impairment and Mild Cognitive Impairment, sponsored by Taipei Medical University. Not yet recruiting. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2024-08-27.

Sponsored by Taipei Medical University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
144
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

This study examines the impact of combining cognitive and physical training, recognizing that daily living often requires individuals to perform multiple tasks simultaneously. The inability to execute such dual movements can hinder daily functioning.

The primary goal is to enhance the ability of individuals with mild cognitive impairment (MCI) to perform two tasks concurrently, focusing on both cognitive and physical aspects. This research aims to deepen our understanding of how multitasking affects patients' abilities and to develop effective intervention programs.

Read the detailed description

The World Health Organization has recognized cognitive impairment as a significant global health issue, encompassing a spectrum of conditions from mild cognitive impairment to various forms of dementia. These conditions are linked to heightened risks of disability and mortality. In the absence of suitable interventions, cognitive functions typically exhibit a gradual decline over time, driven by factors including aging, neurological disorders, traumatic brain injury, and substance abuse.

A thorough literature review indicates that cognitive and physical training can sustain cognitive or physical functions, contingent upon the specific training protocols implemented. Concurrent cognitive and physical training entails the simultaneous execution of multiple cognitive and motor activities, thereby maintaining dual functional control. This innovative training modality integrates motor and cognitive rehabilitation into a cohesive framework.

This clinical trial adopts a randomized controlled design, stratifying participants into four distinct groups: cognitive training, physical training, combined cognitive and physical training, and passive informational activities. The interventions will be administered with a frequency of three times per week over a 12-week period, incorporating task-specific training to enhance both motor and cognitive functions.

02

Conditions studied

  • Cognitive Impairment
  • Mild Cognitive Impairment
03

In context

Cognitive Dysfunction

3,930 studies on the registry are indexed under Cognitive Dysfunction; 1,114 are open to participants now.

This study's planned enrollment of 144 is above the median of 64 across 2,855 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Taipei Medical University is the lead sponsor of 256 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Participants must be aged 60 years or older and able to communicate in Mandarin or Taiwanese.
  2. Mild cognitive impairment, assessed using the Mini Mental State Examination (MMSE) with a score of 14≦MMSE≦25.
  3. Self-reported complaints of cognitive decline.
  4. In addition to the above criteria, participants must voluntarily agree to participate and sign an informed consent form.

Exclusion criteria

Exclusion Criteria:

  1. Individuals with severe psychiatric disorders or behavioral problems, as assessed by the Neuropsychiatric Inventory Questionnaire (NPI-Q) with (a) severity score ≥ 6 and caregiver distress score ≥ 7.
  2. Participants who have undergone other cognitive or activity training within the past six months.
  3. Individuals with sensory impairments, such as visual, auditory, or communication difficulties.
  4. People with mobility impairments, such as those who use wheelchairs or mobility aids.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
144 participants (estimated)

Study arms

  • Experimental
    Cognitive training

    Each participant will receive cognitive training for 45 minutes per session, three sessions per week, for 12 weeks.

    Other: Cognitive training

  • Experimental
    Physical training

    Each participant will receive physical training for 45 minutes per session, three sessions per week, for 12 weeks.

    Other: Physical training

  • Experimental
    Combined cognitive and physical training

    Each participant will receive combined cognitive and physical training for 45 minutes per session, three sessions per week, for 12 weeks.

    Other: Combined cognitive and physical training

  • Active comparator
    Passive information activities

    Each participant will engage in passive information activities for 45 minutes per session, three sessions per week, for 12 weeks.

    Other: Passive information activities

Interventions

  • OtherCognitive training

    Cognitive training will follow a group format, with each group consisting of 4-16 participants. Each group will be in a private, independent room for their training sessions and will not interact with participants from other groups. The cognitive training task components will specifically focus on attention, learning and memory, executive function, perceptual-motor skills, and language.

  • OtherPhysical training

    Physical training will follow a group format, with each group consisting of 4-16 participants. Each group will be in a private, independent room for their training sessions and will not interact with participants from other groups. The physical training task components will specifically focus on strength, balance, agility, gait, low-volume aerobic, and flexibility.

  • OtherCombined cognitive and physical training

    Combined cognitive and physical training will follow a group format, with each group consisting of 4-16 participants. Each group will be in a private, independent room for their training sessions and will not interact with participants from other groups. The combined cognitive and physical training components will specifically focus on a single cognitive task and simultaneously handle a single physical task.

  • OtherPassive information activities

    In passive informational activities, which include a variety of puzzles, audiobooks, and diverse reading materials such as newspapers or listening to news content.

06

What researchers measure

Primary outcomes

  1. Mini-Mental State Examination

    The Mini-Mental State Examination (MMSE) is a standardized instrument for assessing overall cognitive function, where higher scores indicate better global cognition, with a total score ranging from 0 to 30. It is crucial to consider both age and education levels when interpreting the results.

    Time frame: Baseline, 6 weeks (mid), 12 weeks (post-intervention), 3 months, and 6 months after completing the intervention

  2. Wisconsin Card Sorting Test - Computer Version

    The Wisconsin Card Sorting Test (WCST) is a standardized instrument for assessing executive function. Interpreting WCST results includes analyzing the total correct responses and total errors. The total correct responses indicate the number of correct matches made by the participant; a higher number of correct responses suggests better overall cognitive performance and the ability to learn and apply the rules. Conversely, a high number of errors can indicate difficulties in understanding or applying the sorting rules.

    Time frame: Baseline, 6 weeks (mid), 12 weeks (post-intervention), 3 months, and 6 months after completing the intervention

  3. Digit Span Test

    A standardized instrument for assessing working memory.

    Time frame: Baseline, 6 weeks (mid), 12 weeks (post-intervention), 3 months, and 6 months after completing the intervention

  4. Shor-form Berg balance scale

    The Short-Form Berg Balance Scale (SFBBS) is a streamlined assessment tool designed to evaluate an individual's balance and stability. Each item on the SFBBS is scored on a scale from 0 to 4, with 0 indicating the lowest level of function and 4 indicating the highest level of function. The scores for each item are summed to obtain a total score, which provides an overall measure of balance. The maximum possible score varies depending on the number of items included in the short form.

    Time frame: Baseline, 6 weeks (mid), 12 weeks (post-intervention), 3 months, and 6 months after completing the intervention

  5. Back scratch test

    A flexibility test.

    Time frame: Baseline, 6 weeks (mid), 12 weeks (post-intervention), 3 months, and 6 months after completing the intervention

  6. Chair sit-and-reach test

    A flexibility test.

    Time frame: Baseline, 6 weeks (mid), 12 weeks (post-intervention), 3 months, and 6 months after completing the intervention

  7. Grip and pinch strength

    A standardized instrument " PABLO®" for assessing strength.

    Time frame: Baseline, 6 weeks (mid), 12 weeks (post-intervention), 3 months, and 6 months after completing the intervention

  8. Gait analysis

    A standardized instrument " PABLO®" for assessing gait performance.

    Time frame: Baseline, 6 weeks (mid), 12 weeks (post-intervention), 3 months, and 6 months after completing the intervention

Secondary outcomes

  1. Pittsburgh Sleep Quality Index

    The Pittsburgh Sleep Quality Index (PSQI) is a standardized instrument for assessing sleep quality and disturbances over a 1-month period. It evaluates seven domains: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction during the month preceding the test. The total score ranges from 0 to 21 points, with a total score greater than 5 indicating poor sleep.

    Time frame: Baseline, 12 weeks (post-intervention), 3 months, and 6 months after completing the intervention

  2. Insomnia Severity Index

    The Insomnia Severity Index (ISI) is a validated tool for assessing the severity of insomnia symptoms and their impact on daily functioning. The scores for each item are summed to obtain a total score, which ranges from 0 to 28, with higher scores indicating worse sleep. A total score greater than 8 suggests the presence of insomnia.

    Time frame: Baseline, 12 weeks (post-intervention), 3 months, and 6 months after completing the intervention

  3. Actigraphy sleep efficiency (%)

    Sleep parameters were measured using wrist actigraphy (GT9X; Manufacturing Technology, Pensacola, FL, USA) to collect sleep data. Mean sleep efficiency was derived from actigraphy recordings as the ratio of total sleep time to time in bed, multiplied by 100. Restlessness, indicated by a sleep efficiency below 80%, should be carefully considered in elderly individuals.

    Time frame: Baseline, 12 weeks (post-intervention), 3 months, and 6 months after completing the intervention

  4. Actigraphy total sleep time (minutes)

    Sleep parameters are measured by the wrist actigraphy (GT9X; Manufacturing Technology, Pensacola, FL, USA) to collect sleep data. Mean total sleep time derived from actigraphy recordings.

    Time frame: Baseline, 12 weeks (post-intervention), 3 months, and 6 months after completing the intervention

  5. Actigraphy wake duration (minutes)

    Sleep parameters are measured by the wrist actigraphy (GT9X; Manufacturing Technology, Pensacola, FL, USA) to collect sleep data. Mean wake after sleep onset derived from actigraphy recordings.

    Time frame: Baseline, 12 weeks (post-intervention), 3 months, and 6 months after completing the intervention

  6. Actigraphy sleep onset latency (minutes)

    Sleep parameters are measured by the wrist actigraphy (GT9X; Manufacturing Technology, Pensacola, FL, USA) to collect sleep data. Mean sleep onset latency derived from actigraphy recordings. Restlessness, indicated if more than 30-60 minutes, should be carefully considered in elderly individuals.

    Time frame: Baseline, 12 weeks (post-intervention), 3 months, and 6 months after completing the intervention

  7. Actigraphy time in bed (minutes)

    Sleep parameters are measured by the wrist actigraphy (GT9X; Manufacturing Technology, Pensacola, FL, USA) to collect sleep data. Mean time in bed derived from actigraphy recordings.

    Time frame: Baseline, 12 weeks (post-intervention), 3 months, and 6 months after completing the intervention

  8. Actigraphy sleep fragmentation (%)

    Sleep parameters are measured by the wrist actigraphy (GT9X; Manufacturing Technology, Pensacola, FL, USA) to collect sleep data. Sleep fragmentation index (sum of limb movement and fragmentation indexes). The restlessness index during sleep, expressed as a percentage, indicates sleep disruption; higher values mean more disrupted sleep.

    Time frame: Baseline, 12 weeks (post-intervention), 3 months, and 6 months after completing the intervention

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — The investigators do not plan to make individual participant data (IPD) available to other researchers.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06572878
Responsible party
Jia-You, YE (Principal Investigator, Taipei Medical University) — Principal investigator
First posted
Aug 27, 2024
Start date
Aug 2024 (estimated)
Primary completion
Aug 2026 (estimated)
Completion
Feb 2027 (estimated)
Last update
Aug 27, 2024

Study contacts

Jia-You Ye, MSN
Contact
tddey1224@icloud.com
+886-9-03254198

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion